{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:28:08Z","timestamp":1759483688620},"reference-count":16,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1979,7]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 Epsilon aminocaproic acid (EACA) has been used to prevent rebleeding in patients with subarachnoid hemorrhage (SAH). Although this agent does decrease the frequency of rebleeding, several reports have described thrombotic complications of EACA therapy. These complications have included clinical deterioration and intracranial vascular thrombosis in patients with SAH, arteriolar and capillary fibrin thrombi in patients with fibrinolytic syndromes treated with EACA, or other thromboembolic phenomena. Since intravascular fibrin thrombi are often observed in patients with fibrinolytic disorders, EACA should not be implicated in the pathogenesis of fibrin thrombi in patients with disseminated intravascular coagulation or other \u201cconsumption coagulopathies.\u201d<\/jats:p>\n<jats:p content-type=\"fine-print\">This report describes subtotal infarction of the kidney due to thrombosis of a normal renal artery. This occlusion occurred after EACA therapy in a patient with SAH and histopathological documentation of recurrent SAH. The corresponding clinical event was characterized by marked hypertension and abrupt neurological deterioration.<\/jats:p>","DOI":"10.3171\/jns.1979.51.1.0094","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T15:34:15Z","timestamp":1241710455000},"page":"94-97","source":"Crossref","is-referenced-by-count":20,"title":["Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis"],"prefix":"10.3171","volume":"51","author":[{"given":"Raymond R.","family":"Tubbs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanford P.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald E.","family":"Dohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Arch Biochem Biophys","first-page":"153","article-title":"Inhibition of plasmin, trypsin, and the streptokinase-activated fibrinolytic system by \u03f5-aminocaproic acid.","volume":"83","author":"Ablondi","year":"1959"},{"key":"b2","series-title":"J Biol Chem","first-page":"832","article-title":"\u03f5-aminocaproic acid: an inhibitor of plasminogen activation.","volume":"234","author":"Alkjaersig","year":"1959"},{"key":"b3","series-title":"J Clin Pathol","first-page":"488","article-title":"Coagulation and fibrinolytic activity of cerebrospinal fluid.","volume":"31","author":"Anderson","year":"1978"},{"issue":"(6)","key":"b4","series-title":"Med Clin North Am","first-page":"1669","article-title":"Complications of therapy with epsilon-aminocaproic acid.","volume":"50","author":"Bergin","year":"1966"},{"key":"b5","series-title":"N Engl J Med","first-page":"1102","article-title":"Glomerular capillary thrombosis and acute renal failure after epsilon-aminocaproic acid therapy.","volume":"280","author":"Charytan","year":"1969"},{"key":"b6","series-title":"Pathology of the Kidney","first-page":"233","volume":"1","author":"Heptinstall","year":"1974"},{"key":"b7","series-title":"Pathology of the Kidney","first-page":"675","volume":"2","author":"Heptinstall","year":"1974"},{"key":"b8","series-title":"J Neurosurg","first-page":"21","article-title":"Antifibrinolytic therapy for intracranial aneurysms.","volume":"28","author":"Mullan","year":"1968"},{"key":"b9","series-title":"Blood","first-page":"694","article-title":"Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid.","volume":"19","author":"Naeye","year":"1962"},{"key":"b10","series-title":"Stroke","first-page":"622","article-title":"Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.","volume":"6","author":"Nibbelink","year":"1975"},{"key":"b11","series-title":"Acta Med Scand Suppl","first-page":"5","article-title":"Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent. Based on 5 years' clinical experience.","volume":"448","author":"Nilsson","year":"1966"},{"key":"b12","series-title":"Neurochirurgia","first-page":"100","article-title":"The use of antifibrinolytic substances in ruptured intracranial aneurysms.","volume":"12","author":"Norl\u00e9n","year":"1969"},{"key":"b13","series-title":"J Neurosurg","first-page":"480","article-title":"Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid.","volume":"40","author":"Sonntag","year":"1974"},{"key":"b14","series-title":"Am J Med Sci","first-page":"576","article-title":"Aminocaproic acid, an inhibitor of fibrinolysis.","volume":"249","author":"Sweeney","year":"1965"},{"key":"b15","series-title":"Acta Neurol Scand","first-page":"163","article-title":"The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.","volume":"49","author":"Tovi","year":"1973"},{"key":"b16","series-title":"Arch Neurol","first-page":"64","article-title":"Plasminogen in normal and abnormal human cerebrospinal fluid.","volume":"28","author":"Wu","year":"1973"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/51\/1\/article-p94.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/51\/1\/article-p94.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/51\/1\/article-p94.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T22:49:22Z","timestamp":1679266162000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/51\/1\/article-p94.xml"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[1979,7]]},"references-count":16,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/jns.1979.51.1.0094","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1979,7]]}}}